Edition:
India

Aeglea Bio Therapeutics Inc (AGLE.OQ)

AGLE.OQ on NASDAQ Stock Exchange Global Market

7.95USD
22 Aug 2019
Change (% chg)

-- (--)
Prev Close
$7.95
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
43,050
52-wk High
$11.16
52-wk Low
$5.99

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Jun '19 0.00 -0.549
Mar '19 0.00 -0.592
FY 2018 Dec '18 0.00 -0.621
Sep '18 0.00 -0.542
Jun '18 2.38 -0.457
Mar '18 1.51 -0.487
FY 2017 Dec '17 1.48 -0.391
Sep '17 1.26 -0.480
Jun '17 1.48 -0.470
Mar '17 0.98 -0.467
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-19 5 0.00 0.00 0.00 0.80
Quarter Ending Dec-19 5 0.00 0.00 0.00 0.90
Year Ending Dec-19 6 0.50 3.00 0.00 2.63
Year Ending Dec-20 6 13.27 79.60 0.00 8.79
Earnings (per share)
Quarter Ending Sep-19 6 -0.52 -0.46 -0.58 -0.67
Quarter Ending Dec-19 6 -0.53 -0.42 -0.62 -0.67
Year Ending Dec-19 6 -2.19 -2.02 -2.34 -2.28
Year Ending Dec-20 6 -2.00 -1.27 -2.54 -1.96
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -23.94 -- --
EPS (TTM) % -119.80 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aeglea Bio Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 24.07 19.79 84 --
13 Week 57.37 49.71 91 --
26 Week -26.41 -32.01 25 --
52 Week -23.68 -35.31 35 --
YTD 22.64 7.71 62 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 79.72%
# of Holders: 119
Total Shares Held: 23,027,437
3 Mo. Net Change: 347,655
# New Positions: 21
# Closed Positions: 10
# Increased Positions: 72
# Reduced Positions: 28
# Net Buyers: 44
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.